Journal of Inflammation Research
Volume 14, 2021 - Issue
Clinical Trial Report
Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive EGFR Mutations: A Single-Center, Open-Label, Single-Arm, Phase II Clinical Trial
, 
, , &
Meifang LiDepartment of Thoracic Medical Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou City, Fujian Province, 350014, People’s Republic of Chinahttps://orcid.org/0000-0002-5204-8386View further author information
https://orcid.org/0000-0002-5204-8386View further author information, , & Zhiyong HeDepartment of Thoracic Medical Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou City, Fujian Province, 350014, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-0793-8598View further author information
https://orcid.org/0000-0003-0793-8598View further author information